Extensive multifocal and pleomorphic pulmonary lesions in Waldenström macroglobulinemia: A case report.

Amyloidosis Case report Computed tomography Lung Waldenström macroglobulinemia

Journal

World journal of clinical cases
ISSN: 2307-8960
Titre abrégé: World J Clin Cases
Pays: United States
ID NLM: 101618806

Informations de publication

Date de publication:
06 Jun 2020
Historique:
received: 24 12 2019
revised: 13 03 2020
accepted: 13 05 2020
entrez: 18 6 2020
pubmed: 18 6 2020
medline: 18 6 2020
Statut: ppublish

Résumé

Waldenström macroglobulinemia (WM) is a type of small lymphocytic lymphoma that mainly affects the bone marrow, spleen, and lymph nodes. A subset of patients with WM demonstrates extramedullary involvement (4.4%), and the most frequent extramedullary disease site involved is the lungs (30%). A 60-year-old male patient who experienced intermittent breath-holding for 6 mo was admitted on August 14, 2017. Chest computed tomography indicated multiple pulmonary cavities in the upper lobes of both lungs, with pulmonary consolidation, ground-glass opacities, patchy infiltrates, fibrous bands, large bullae, and enlarged lymph nodes in the mediastinum. The patient was a heavy smoker (20 cigarettes/d for 40 years). Diagnostic fiberoptic bronchoscopy revealed normal findings. Serological examination revealed a remarkable increase in serum immunoglobulin M levels (30.24 g/L; normal: 0.4-2.30 g/L). A computed tomography-guided percutaneous pulmonary biopsy was performed in the left lower lobe of the lung with pulmonary consolidation and indicated that the alveolar structure disappeared and that a large amount of amyloid-like deposition was present along with the infiltration of very few lymphocytes and plasma cells. The patient was treated with the combined treatment of dexamethasone + rituximab + lenalidomide over four courses. Serum immunoglobulin M did not normalize, and he received ibrutinib + dexamethasone. This patient with WM and lung amyloidosis had a wide range of pulmonary lesions and a variety of morphological features, which was a rare case. Yet, some changes might be ascribed to heavy smoking.

Sections du résumé

BACKGROUND BACKGROUND
Waldenström macroglobulinemia (WM) is a type of small lymphocytic lymphoma that mainly affects the bone marrow, spleen, and lymph nodes. A subset of patients with WM demonstrates extramedullary involvement (4.4%), and the most frequent extramedullary disease site involved is the lungs (30%).
CASE SUMMARY METHODS
A 60-year-old male patient who experienced intermittent breath-holding for 6 mo was admitted on August 14, 2017. Chest computed tomography indicated multiple pulmonary cavities in the upper lobes of both lungs, with pulmonary consolidation, ground-glass opacities, patchy infiltrates, fibrous bands, large bullae, and enlarged lymph nodes in the mediastinum. The patient was a heavy smoker (20 cigarettes/d for 40 years). Diagnostic fiberoptic bronchoscopy revealed normal findings. Serological examination revealed a remarkable increase in serum immunoglobulin M levels (30.24 g/L; normal: 0.4-2.30 g/L). A computed tomography-guided percutaneous pulmonary biopsy was performed in the left lower lobe of the lung with pulmonary consolidation and indicated that the alveolar structure disappeared and that a large amount of amyloid-like deposition was present along with the infiltration of very few lymphocytes and plasma cells. The patient was treated with the combined treatment of dexamethasone + rituximab + lenalidomide over four courses. Serum immunoglobulin M did not normalize, and he received ibrutinib + dexamethasone.
CONCLUSION CONCLUSIONS
This patient with WM and lung amyloidosis had a wide range of pulmonary lesions and a variety of morphological features, which was a rare case. Yet, some changes might be ascribed to heavy smoking.

Identifiants

pubmed: 32548160
doi: 10.12998/wjcc.v8.i11.2305
pmc: PMC7281034
doi:

Types de publication

Case Reports

Langues

eng

Pagination

2305-2311

Informations de copyright

©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict-of-interest statement: The authors declare that they have no conflict of interest.

Références

Blood. 2015 Sep 10;126(11):1392-4
pubmed: 26359434
Arch Pathol Lab Med. 2017 Feb;141(2):247-254
pubmed: 28134587
Intern Med. 2015;54(3):353-4
pubmed: 25748748
Am J Hematol. 2015 Feb;90(2):100-4
pubmed: 25349134
Br J Haematol. 2015 Jan;168(2):207-18
pubmed: 25312307
Drugs Future. 2010 Jan;35(1):53-58
pubmed: 21869855
Acta Haematol. 2001;105(2):92-6
pubmed: 11408711
Br J Haematol. 2014 May;165(3):316-33
pubmed: 24528152
Ren Fail. 2012;34(9):1173-6
pubmed: 22950818

Auteurs

De-Feng Zhao (DF)

Department of Hematology, Beijing Boren Hospital, Beijing 100070, China.

Hao-Yong Ning (HY)

Department of Pathology, Navy General Hospital of PLA, Beijing 100048, China.

Jian Cen (J)

Department of Hematology, Navy General Hospital of PLA, Beijing 100048, China.

Yi Liu (Y)

Department of Hematology, Navy General Hospital of PLA, Beijing 100048, China.

Li-Ren Qian (LR)

Department of Hematology, Navy General Hospital of PLA, Beijing 100048, China.

Zhi-Hai Han (ZH)

Department of Respiratory Care, Navy General Hospital of PLA, Beijing 100048, China.

Jian-Liang Shen (JL)

Department of Hematology, Navy General Hospital of PLA, Beijing 100048, China. nghxyk@163.com.

Classifications MeSH